Sangamo BioSciences Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
26,624.00
26,417.00
40,703.00
71,658.00
54,568.00
68,889
Depreciation, Depletion & Amortization
569.00
549.00
988.00
997.00
1,498.00
2,359
Other Funds
2,015.00
4,556.00
12,906.00
776.00
654.00
10,416
Funds from Operations
18,937.00
15,340.00
32,810.00
55,298.00
44,562.00
56,114
Changes in Working Capital
225.00
9,665.00
910.00
10,585.00
55,741.00
93,266
Net Operating Cash Flow
19,162.00
5,675.00
33,720.00
65,883.00
11,179.00
37,152
Capital Expenditures
432.00
621.00
2,411.00
732.00
3,751.00
Sale of Fixed Assets & Businesses
79.00
-
-
-
-
Purchase/Sale of Investments
67,765.00
100,037.00
79,873.00
18,857.00
73,653.00
Net Investing Cash Flow
68,118.00
100,658.00
77,462.00
18,125.00
80,904.00
Net Financing Cash Flow
76,107.00
102,177.00
19,710.00
337.00
97,490.00
Net Change in Cash
11,173.00
4,156.00
63,452.00
47,421.00
27,765.00
Free Cash Flow
19,594.00
6,296.00
36,131.00
66,615.00
7,428.00
Change in Capital Stock
78,122.00
106,733.00
6,804.00
1,113.00
98,144.00
Other Uses
-
-
-
-
3,500.00
About Sangamo BioSciences
View Profile
